BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17451368)

  • 1. Cnot7-null mice exhibit high bone mass phenotype and modulation of BMP actions.
    Washio-Oikawa K; Nakamura T; Usui M; Yoneda M; Ezura Y; Ishikawa I; Nakashima K; Noda T; Yamamoto T; Noda M
    J Bone Miner Res; 2007 Aug; 22(8):1217-23. PubMed ID: 17451368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation.
    Morinobu M; Nakamoto T; Hino K; Tsuji K; Shen ZJ; Nakashima K; Nifuji A; Yamamoto H; Hirai H; Noda M
    J Exp Med; 2005 Mar; 201(6):961-70. PubMed ID: 15781586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
    Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
    Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of LacZ gene placed in the locus of Cnot7 exhibits its activity in osteoblasts in vivo and in mineralized nodules in vitro.
    Washio-Oikawa K; Nakamura T; Usui M; Yoneda M; Ezura Y; Ishikawa I; Nakashima K; Yamamoto T; Noda M
    J Cell Biochem; 2006 Oct; 99(2):538-44. PubMed ID: 16639713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice.
    Schindeler A; Ramachandran M; Godfrey C; Morse A; McDonald M; Mikulec K; Little DG
    J Orthop Res; 2008 Jan; 26(1):65-74. PubMed ID: 17787010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function.
    Gazzerro E; Deregowski V; Stadmeyer L; Gale NW; Economides AN; Canalis E
    Bone; 2006 Dec; 39(6):1252-60. PubMed ID: 16934545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model.
    Zhu W; Rawlins BA; Boachie-Adjei O; Myers ER; Arimizu J; Choi E; Lieberman JR; Crystal RG; Hidaka C
    J Bone Miner Res; 2004 Dec; 19(12):2021-32. PubMed ID: 15537446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein regulation of forkhead/winged helix transcription factor Foxc2 (Mfh1) in a murine mesodermal cell line C1 and in skeletal precursor cells.
    Nifuji A; Miura N; Kato N; Kellermann O; Noda M
    J Bone Miner Res; 2001 Oct; 16(10):1765-71. PubMed ID: 11585339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory helix-loop-helix transcription factors Id1/Id3 promote bone formation in vivo.
    Maeda Y; Tsuji K; Nifuji A; Noda M
    J Cell Biochem; 2004 Oct; 93(2):337-44. PubMed ID: 15368360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
    Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
    J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
    Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
    J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
    Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
    Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.
    Morvan F; Boulukos K; Clément-Lacroix P; Roman Roman S; Suc-Royer I; Vayssière B; Ammann P; Martin P; Pinho S; Pognonec P; Mollat P; Niehrs C; Baron R; Rawadi G
    J Bone Miner Res; 2006 Jun; 21(6):934-45. PubMed ID: 16753024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells.
    Kim DJ; Moon SH; Kim H; Kwon UH; Park MS; Han KJ; Hahn SB; Lee HM
    Spine (Phila Pa 1976); 2003 Dec; 28(24):2679-84. PubMed ID: 14673369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired growth plate function in bmp-6 null mice.
    Perry MJ; McDougall KE; Hou SC; Tobias JH
    Bone; 2008 Jan; 42(1):216-25. PubMed ID: 17980691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
    Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
    J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full-length bovine spp24 [spp24 (24-203)] inhibits BMP-2 induced bone formation.
    Sintuu C; Murray SS; Behnam K; Simon R; Jawien J; Silva JD; Duarte ME; Brochmann EJ
    J Orthop Res; 2008 Jun; 26(6):753-8. PubMed ID: 18253966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo.
    Chikazu D; Li X; Kawaguchi H; Sakuma Y; Voznesensky OS; Adams DJ; Xu M; Hoshio K; Katavic V; Herschman HR; Raisz LG; Pilbeam CC
    J Bone Miner Res; 2002 Aug; 17(8):1430-40. PubMed ID: 12162497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.